Back to STATE STREET CORP STATE STREET CORP

MYGNMYGN
Showing 8 of 11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in MYRIAD GENETICS INC

STATE STREET CORP holds 5M shares of MYGN (MYRIAD GENETICS INC), worth $28.5M as of 2026-Q2. The position was increased (+12.7% shares). MYGN represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$28.5M

Current Shares

5M

Total Value Change

-$100.4M

Total Shares Change

+281,618

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5M
+12.7%
$28.5M0.0%$5.71
32
2026-Q1
Decreased
4.4M
-25.9%
$19.9M0.0%$5.29
0
2025-Q4
Increased
6M
+19.9%
$36.7M0.0%$6.17
34
2025-Q3
Increased
5M
+3.5%
$36M0.0%$7.24
30
2025-Q2
Decreased
4.8M
-8.7%
$25.5M0.0%$5.25
0
2025-Q1
Decreased
5.3M
-4.7%
$46.7M0.0%$8.88
0
2024-Q4
Increased
5.5M
+17.5%
$75.8M0.0%$13.63
35
2024-Q3
Increased
4.7M
+8.3%
$128.8M0.0%$26.46
33

Other major holders of MYGN: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., BAILLIE GIFFORD & CO, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used